340 related articles for article (PubMed ID: 29894509)
1. Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease.
Coetzee LM; Cassim N; Sriruttan C; Mhlanga M; Govender NP; Glencross DK
PLoS One; 2018; 13(6):e0198993. PubMed ID: 29894509
[TBL] [Abstract][Full Text] [Related]
2. Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa.
Cassim N; Schnippel K; Coetzee LM; Glencross DK
PLoS One; 2017; 12(2):e0171675. PubMed ID: 28166254
[TBL] [Abstract][Full Text] [Related]
3. Estimating the cost-per-result of a national reflexed Cryptococcal antigenaemia screening program: Forecasting the impact of potential HIV guideline changes and treatment goals.
Cassim N; Coetzee LM; Schnippel K; Glencross DK
PLoS One; 2017; 12(8):e0182154. PubMed ID: 28829788
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal.
Drain PK; Kleene JM; Coleman SM; Losina E; Katz JN; Giddy J; Ross D; Freedberg KA; Bassett IV
HIV Med; 2015 Nov; 16(10):640-4. PubMed ID: 25958770
[TBL] [Abstract][Full Text] [Related]
5. Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment.
Sawadogo S; Makumbi B; Purfield A; Ndjavera C; Mutandi G; Maher A; Kaindjee-Tjituka F; Kaplan JE; Park BJ; Lowrance DW
PLoS One; 2016; 11(10):e0161830. PubMed ID: 27760140
[TBL] [Abstract][Full Text] [Related]
6. Serum Cryptococcal Antigen Testing in Immunosuppressed HIV-positive Children and Adolescents.
Zuma P; Ramsamy Y; Mlisana K; Archary M
Pediatr Infect Dis J; 2020 Mar; 39(3):217-220. PubMed ID: 31725553
[TBL] [Abstract][Full Text] [Related]
7. Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa.
Larson BA; Rockers PC; Bonawitz R; Sriruttan C; Glencross DK; Cassim N; Coetzee LM; Greene GS; Chiller TM; Vallabhaneni S; Long L; van Rensburg C; Govender NP
PLoS One; 2016; 11(7):e0158986. PubMed ID: 27390864
[TBL] [Abstract][Full Text] [Related]
8. Identification of Cryptococcus antigen in human immunodeficiency virus-positive Turkish patients by using the Dynamiker
Karaman E; Ilkit M; Kuşçu F
Mycoses; 2019 Oct; 62(10):961-968. PubMed ID: 31344286
[TBL] [Abstract][Full Text] [Related]
9. Laboratory Reflex and Clinic-Based Point-of-Care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality Among People Living With HIV.
Drain PK; Galagan SR; Govere S; Krows M; Thulare H; Wallis CL; Gosnell BI; Moosa MY; Celum C; Bassett IV
J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1205-1213. PubMed ID: 33990495
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
[TBL] [Abstract][Full Text] [Related]
11. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
[TBL] [Abstract][Full Text] [Related]
12. Validation of clinic-based cryptococcal antigen lateral flow assay screening in HIV-infected adults in South Africa.
Drain PK; Hong T; Krows M; Govere S; Thulare H; Wallis CL; Gosnell BI; Moosa MY; Bassett IV; Celum C
Sci Rep; 2019 Feb; 9(1):2687. PubMed ID: 30804356
[TBL] [Abstract][Full Text] [Related]
13. Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.
Mamuye AT; Bornstein E; Temesgen O; Blumberg HM; Kempker RR
Am J Trop Med Hyg; 2016 Oct; 95(4):786-792. PubMed ID: 27527636
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
[TBL] [Abstract][Full Text] [Related]
16. Impact of prior cryptococcal antigen screening on in-hospital mortality in cryptococcal meningitis or fungaemia among HIV-seropositive individuals in South Africa: a cross-sectional observational study.
Paccoud O; Shuping L; Mashau R; Greene G; Quan V; Meiring S; Govender NP;
Clin Microbiol Infect; 2023 Aug; 29(8):1063-1069. PubMed ID: 37086780
[TBL] [Abstract][Full Text] [Related]
17. Retrospective Assessment of a National Reflex Cryptococcal Antigen Screening Program in South Africa Through Interlaboratory Comparison of Lateral Flow Assay Results.
Blasich NP; Coetzee LM; Sriruttan C; DeSanto D; Greene GS; Glencross DK; Govender NP
Lab Med; 2022 Nov; 53(6):614-618. PubMed ID: 35660925
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda.
Andama AO; den Boon S; Meya D; Cattamanchi A; Worodria W; Davis JL; Walter ND; Yoo SD; Kalema N; Haller B; Huang L;
J Acquir Immune Defic Syndr; 2013 Jun; 63(2):189-94. PubMed ID: 23542636
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease.
Tenforde MW; Boyer-Chammard T; Muthoga C; Tawe L; Milton T; Rulaganyang I; Lechiile K; Rukasha I; Leeme TB; Govender NP; Ngidi J; Mine M; Molloy SF; Harrison TS; Lortholary O; Jarvis JN
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087436
[TBL] [Abstract][Full Text] [Related]
20. Multicenter Cryptococcal Antigen Screening of HIV-Infected Patients in Iran.
Bandalizadeh Z; Shokohi T; Moosazadeh M; Keikha N; Seyedpor H; Rabie Rudsari M; Babamahmoudi F; Ghasemian R; Mardani M; Javanian M; Soleimanpour S; Sefidgar AA; Shokri M; Gouya MM; Seyedmousavi S
Curr Microbiol; 2020 Aug; 77(8):1667-1672. PubMed ID: 32296917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
